{
  "id" : "extension_bfp",
  "algorithm" : "eod_public",
  "version" : "3.3",
  "name" : "EOD Primary Tumor",
  "title" : "EOD Primary Tumor",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017\n\n(5) Woltering, E.A., Bergsland, E.K., et al. **Neuroendocrine Tumors of the Jejunum and Ileum**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017\n\n(6) **Neuroendocrine Tumors of the Jejunum and Ileum**, from the AJCC Cancer Staging System Version 9 (2023). Used with permission of the American College of Surgeons, Chicago, Illinois.",
  "last_modified" : "2025-11-14T20:05:47.495Z",
  "definition" : [ {
    "key" : "eod_primary_tumor",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  }, {
    "key" : "ss2018_t",
    "name" : "SS2018 T",
    "type" : "ENDPOINT"
  } ],
  "rows" : [ [ "000", "In situ, intraepithelial, noninvasive", "VALUE:IS" ], [ "100", "Tumor less than or equal to 1 cm AND confined to\n- Intramucosal, NOS\n- Lamina propria (including in a polyp)\n- Mucosa, NOS\n- Muscularis mucosae (including in a polyp)\n- Submucosa (superficial invasion) (including in a polyp)\n\nLocalized, NOS", "VALUE:L" ], [ "200", "Tumor greater than 1 cm\n\nOR Invades muscularis propria \nInvasion of muscularis, NOS", "VALUE:L" ], [ "300", "Invasion through muscularis propria\nExtension through wall, NOS\nSubserosal tissue/(sub)serosal fat invaded\nTransmural, NOS \nWall, NOS", "VALUE:L" ], [ "500", "Adjacent (connective) tissue(s), NOS (without serosal penetration)\nFat, NOS\nMesenteric fat\nMesentery (adjacent loops of bowel)\nNonperitonealized perimuscular tissue\nRetroperitoneum", "VALUE:RE" ], [ "600", "Invasion of/through serosa (mesothelium) (tunica serosa) (visceral peritoneum)\n\nAbdominal wall\nColon (including appendix)\nOther segments of the small intestine via serosa\nRetroperitoneum invaded greater than 2 cm in depth", "VALUE:RE" ], [ "700", "Bladder\nFallopian tube(s)\nOvary(ies)\nUterus\n\nFurther contiguous extension", "VALUE:D" ], [ "800", "No evidence of primary tumor", "VALUE:U" ], [ "999", "Unknown; extension not stated\nPrimary tumor cannot be assessed\nNot documented in medical record\n\nDeath Certificate Only", "VALUE:U" ] ]
}